The past decade has seen growing efforts in developing methods toward the functionalization of five-membered nitrogen-containing heterocycles.^[@ref1]^ Their unique biological properties and their ability to engage in hydrogen bond interactions has rendered these subunits useful components of medicinally relevant molecules.^[@ref2]^ Among these compounds, five-membered aminoheterocycles such as aminoimidazoles^[@cit3a],[@cit3b]^ and aminopyrazoles^[@cit3c],[@cit3d]^ have attracted considerable interest (Figure [1](#fig1){ref-type="fig"}).

![Biologically active compounds containing aminopyrazole and aminoimidazole subunits.](ol-2013-035947_0001){#fig1}

An obvious means to prepare aminoheterocycles is by using the palladium-catalyzed C--N cross-coupling between five-membered heterocyclic halides and amines.^[@ref4],[@ref5]^ Despite the significant advances in palladium-catalyzed C--N cross-coupling methods, five-membered heterocyclic halides represent difficult coupling partners,^[@ref6]^ presumably due to their ability to inhibit and/or deactivate the palladium catalyst.^[@ref7]^ While success has been made with halothiophenes and halofurans,^[@ref8]^ and very recently haloimidazoles and halopyrazoles,^[@ref4],[@cit8d]^ the use of five-membered heterocycles bearing unprotected NH groups as electrophiles in palladium-catalyzed C--N cross-coupling reactions is comparatively rare^[@ref9]^ and limited to specific substrate combinations.^[@ref4],[@ref10]^ Herein, we present a general method for the palladium-catalyzed amination of a number of unprotected bromoimidazoles and bromopyrazoles.

###### Ligand Effects in the Palladium-Catalyzed Amination of 4-Bromo-1*H*-imidazole[a](#t1fn1){ref-type="table-fn"}
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  entry   precatalyst   ligand   conversion[b](#t1fn2){ref-type="table-fn"} (%)   yield[b](#t1fn2){ref-type="table-fn"} (%)
  ------- ------------- -------- ------------------------------------------------ -------------------------------------------
  1       **P1**        **L1**   27                                               13
  2       **P2**        **L2**   7                                                0
  3       **P3**        **L3**   100                                              77
  4       **P4**        **L4**   100                                              85 (87)[c](#t1fn3){ref-type="table-fn"}
  5       **P5**        **L5**   4                                                0
  6       **P6**        **L6**   8                                                0

Reaction conditions: HetArBr (0.3 mmol), aniline (0.36 mmol), LHMDS (0.66 mmol).

Determined based on the ^1^H NMR of the crude reaction mixture using 1,3,5-trimethoxybenzene as internal standard, average of two runs.

rt, 12 h.

We initiated our investigation by examining the palladium-catalyzed coupling between test substrates 4-bromo-1*H*-imidazole and aniline. As depicted in Table [1](#tbl1){ref-type="other"}, we observed dramatic ligand effects in these initial experiments. For example, **L1** and **L2** were previously reported to be effective for the coupling between 4-bromo-1*H*-pyrazole and aniline;^[@ref4],[@cit11a]^ however, these ligands proved to be ineffective for the coupling of the 4-bromo-1*H*-imidazole as the electrophile (entries 1 and 2). Conversely, the use of **L3**, previously developed for the amidation of five-membered heterocyclic bromides,^[@cit8d]^ resulted in the full conversion of the bromoimidazole and 77% yield of the corresponding 4-amino adduct (entry 3). The use of a catalyst based on **L4**([@cit11b]) performed comparably, providing the desired amination product in slightly higher yield (85%) under otherwise identical conditions (entry 4). Notably, this process could be carried out at room temperature, affording the product in 87% yield in 12 h. Interestingly, these results contrast with our previous observation that **L4** was inferior to the bulkier **L3** in the amidation reactions of five-membered heterocyclic bromides.^[@cit8d]^ However, amines are significantly more nucleophilic than amides, and the use of **L3**, which bears the large 1-adamantyl substituents on phosphorus, is presumably unnecessary to facilitate reductive elimination. Finally, reactions employing catalysts derived from **L5**([@cit11c]) or **L6**([@cit11d]) yielded no desired product (entries 5 and 6), thus providing further information on the importance of the BrettPhos biaryl backbone framework (such as in **L3** and **L4**) to effect amination of these types of heterocycles.^[@cit11e]^
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Using this optimized protocol, with **P4** (1--2 mol %), **L4** (1--2 mol %), and LHMDS (2.2 equiv) in THF,^[@ref12]^ we assessed the scope of the amine coupling partners for the amination of 4-bromo-1*H*-imidazole (Scheme [1](#sch1){ref-type="scheme"}). This system was found to be effective for electron-rich (**1a** and **1b**), electron-deficient (**1c** and **1d**), and heteroarylamines (**1e**, **1f**, and **1g**).^[@ref13]^ Notably, there exist very few examples of preparing 4-aminoimidazoles that have appeared to date.^[@ref14]^ In addition, this investigation was extended to the amination of 2-bromo-1*H*-imidazoles. As shown in Scheme [1](#sch1){ref-type="scheme"}, a variety of amine nucleophiles including anilines (**1h**, **1j**, and **1k**), alkylamines (**1i**), and heteroarylamines (**1l**) underwent efficient arylation to afford 2-aminoimidazoles in good yields.

Next, we turned our attention to amination reactions using 4- and 3-bromo-1*H*-pyrazoles as electrophiles. Under the optimized reaction conditions, various aliphatic and aromatic amines of different electronic and steric properties represent useful coupling partners for the transformation (Scheme [2](#sch2){ref-type="scheme"}). Substituents such as phenoxy (**2c**), trifluoromethyl (**2d**), cyano (**2f**), morpholinyl (**2h**), and furanyl (**2j**) were also well tolerated, although coupling products with aminophenols and aminoacetanilide functional groups could not be prepared in useful yields.
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There has also been an increasing interest in the synthesis of diheteroarylamines,^[@ref15]^ as these compounds have displayed promising activity in assays targeting cancer,^[@cit15a],[@cit15b]^ myeloproliferative disorders^[@cit15c],[@cit15d]^ and platelet aggregation.^[@cit15e]^ Therefore, we evaluated the utility of this protocol toward the synthesis of a variety of diheteroarylamines from 4- and 3-bromo-1*H*-pyrazoles and a range of interesting heteroaromatic amines (Scheme [2](#sch2){ref-type="scheme"}). Various aminoheterocycles such as aminopyridines (**2k**, **2i**, and **2p**), aminoquinolines (**2m**), aminopyrimidines (**2n** and **2r**), and aminopyrazines (**2o** and **2q**) were found to be suitable coupling partners, although in the case of **2q** and **2r**, higher catalyst loadings and longer reaction times were necessary. Unfortunately, 4-aminopyridine and 8-aminoquinoline were not successfully transformed under our reaction conditions.

In conclusion, we have developed a general method to cross-couple 4- and 2-bromo-1*H*-imidazoles and 4- and 3-bromo-1*H*-pyrazoles effectively with aliphatic, aromatic, and heteroaromatic amines. In particular, this method provides facile access to 4-aminoimidazoles and diheteroarylamines. We anticipate that this protocol will find widespread application in a variety of settings to access these types of substituted five-membered heterocycles that are traditionally difficult to prepare.

Experimental procedures along with experimental and spectroscopic data for new compounds. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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